| 10.925 -0.045 (-0.41%) | 08-12 12:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.86 | 1-year : | 16.2 |
| Resists | First : | 11.87 | Second : | 13.86 |
| Pivot price | 10.97  |
|||
| Supports | First : | 10.1 | Second : | 9.01 |
| MAs | MA(5) : | 11.21 |
MA(20) : | 10.8 |
| MA(100) : | 9.75 |
MA(250) : | 10.48 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 51.4 |
D(3) : | 64 |
| RSI | RSI(14): 54.3 |
|||
| 52-week | High : | 15.47 | Low : | 7.71 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ARDT ] has closed above bottom band by 45.5%. Bollinger Bands are 9.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.34 - 11.41 | 11.41 - 11.46 |
| Low: | 10.8 - 10.89 | 10.89 - 10.95 |
| Close: | 10.85 - 10.98 | 10.98 - 11.08 |
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Tue, 11 Aug 2026
A next-generation heart pump is tested during high-risk stenting - Stock Titan
Sun, 09 Aug 2026
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
Fri, 07 Aug 2026
Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Thu, 06 Aug 2026
Ardent Health (ARDT) Stock Climbs Even As Margins Tighten Sharply - Sahm
Wed, 05 Aug 2026
Why Ardent Health (ARDT) Is Down 6.3% After Cutting 2026 Earnings Guidance On Weaker Q2 Results - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 143 (M) |
| Shares Float | 53 (M) |
| Held by Insiders | 23.6 (%) |
| Held by Institutions | 75.7 (%) |
| Shares Short | 4,610 (K) |
| Shares Short P.Month | 3,630 (K) |
| EPS | 0.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.34 |
| Profit Margin | 1.2 % |
| Operating Margin | 3.4 % |
| Return on Assets (ttm) | 3.1 % |
| Return on Equity (ttm) | 9.9 % |
| Qtrly Rev. Growth | -1.4 % |
| Gross Profit (p.s.) | 26.08 |
| Sales Per Share | 44.71 |
| EBITDA (p.s.) | 2.94 |
| Qtrly Earnings Growth | -77.1 % |
| Operating Cash Flow | 514 (M) |
| Levered Free Cash Flow | 208 (M) |
| PE Ratio | 19.83 |
| PEG Ratio | 0 |
| Price to Book value | 1.16 |
| Price to Sales | 0.24 |
| Price to Cash Flow | 3.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|